RxDoctor Payments Data

George Birks, MD

Internal Medicine · Pueblo, CONPI 1659338499

Payments from drug & device makers

$4,400in general payments, 2019–2025

Across 257 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$701
  • Novo Nordisk$529
  • AbbVie$443
  • Johnson & Johnson$262
  • Lilly USA, LLC$252
  • Pfizer$220
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$4,400100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,400 in reported general payments places this provider in the 90th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$176,135
Medicare patients
265
Services billed
2,508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban89$77,558
XareltoRivaroxaban57$55,777
OzempicSemaglutide52$47,494
MyrbetriqMirabegron43$36,457
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$28,681
FarxigaDapagliflozin Propanediol23$25,358
LinzessLinaclotide26$24,996
TrulicityDulaglutide11$21,056
JardianceEmpagliflozin12$17,207
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$13,801
MounjaroTirzepatide14$13,381
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$9,921
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$8,503
Lantus SolostarInsulin Glargine,hum.Rec.Anlog54$7,141
SymbicortBudesonide/Formoterol Fumarate19$7,097

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$220$84,448103 claims
Johnson & JohnsonXarelto$262$55,77757 claims
Novo NordiskOzempic$529$47,49452 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$701$46,25664 claims
GSKTrelegy Ellipta, Anoro Ellipta$103$37,18446 claims
Astellas Pharma US IncMyrbetriq$152$36,45743 claims
Lilly USA, LLCTrulicity, Mounjaro$252$34,43725 claims
AbbVieLinzess, Creon, Synthroid$443$34,03691 claims
Boehringer IngelheimJardiance$91$17,20712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,430 internal medicine providers in Colorado.

Other internal medicine in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →